title: The Use of Fall Risk Increasing Drugs (FRIDs) in Patients With Dizziness Presenting to a Neurotology Clinic.
abstract: OBJECTIVE
  To characterize the use of fall risk increasing drugs (FRIDs) in patients with dizziness who presented to a Neurotology academic practice and to evaluate for predictors of FRID use in this population.
  
  
  METHODS
  A total of 292 subjects presented with dizziness between July 1, 2013 and December 31, 2013.
  
  
  METHODS
  Demographic information and FRID use were recorded.
  
  
  METHODS
  The prevalence and type of FRIDs (psychotropics, antihypertensives, and/or narcotics) used among participants.
  
  
  RESULTS
  The overall prevalence of any FRID use was 40.8%. Thirty-nine percent of patients were on psychotropic medications, 37% on antihypertensives, and 8.2% on narcotics. The proportion of patients on two or more FRIDs at presentation was 34%. When categorizing by age group, 40% of patients aged 50 years or greater versus 24% of younger patients (p = 0.004) were on two or more FRIDs. With every decade increase in age, the odds of being on two or more FRIDs increased by 7%.
  
  
  CONCLUSIONS
  Forty percent of all patients presenting to a Neurotology Clinic for dizziness were on a FRID. Older patients were significantly more likely to be on multiple FRIDs, specifically antihypertensives and narcotic medications. These findings suggest that to fully assess and treat older patients with dizziness, the use of these medications should be evaluated.
authors.affiliation: The Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Baltimore, Maryland, U.S.A.
authors.forename: Aisha
authors.initials: A
authors.lastname: Harun
authors.forename: Yuri
authors.initials: Y
authors.lastname: Agrawal
mesh_terms: D000058:Accidental Falls; D000328:Adult; D000368:Aged; D004244:Dizziness / Q000139:chemically induced* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012189:Retrospective Studies; D012306:Risk; D014717:Vertigo
chemical_list: D011619:Psychotropic Drugs
references.citation: Br J Clin Pharmacol. 2007 Feb;63(2):232-7
references.pmid: 16939531
references.citation: Am J Geriatr Pharmacother. 2007 Dec;5(4):345-51
references.pmid: 18179993
references.citation: Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):499-508
references.pmid: 15353388
references.citation: BMC Geriatr. 2014;14:40
references.pmid: 24674152
references.citation: Age Ageing. 2015 Jan;44(1):90-6
references.pmid: 25313240
references.citation: Arch Intern Med. 2009 May 25;169(10):938-44
references.pmid: 19468085
references.citation: Age Ageing. 2006 Sep;35 Suppl 2:ii37-ii41
references.pmid: 16926202
references.citation: Am J Med. 1999 Nov;107(5):468-78
references.pmid: 10569302
references.citation: JAMA. 2002 Jan 16;287(3):337-44
references.pmid: 11790213
references.citation: J Am Geriatr Soc. 2008 Aug;56(8):1409-16
references.pmid: 18662210
references.citation: J Am Geriatr Soc. 2004 Oct;52(10):1719-23
references.pmid: 15450051
references.citation: Ann Intern Med. 1992 Dec 1;117(11):898-904
references.pmid: 1443950
references.citation: Arch Intern Med. 1995 Sep 11;155(16):1801-7
references.pmid: 7654115
references.citation: Arch Intern Med. 2009 Nov 23;169(21):1952-60
references.pmid: 19933955